This contract opportunity involves the establishment of non-exclusive discount contracts for medications containing the active ingredients Olodaterol and Tiotropium Bromide. The contracts will be in effect from October 1, 2025, to September 30, 2027, with the possibility of entering into contracts a
432 days left to bid. Opened 9 months ago, deadline 31 Jul 2027.
The AOK Rheinland-Pfalz/Saarland - The Health Fund is issuing a framework agreement for "Seating Furniture" consisting of a total of 4 lots. This specific tender is for Lot 3, which involves establishing a framework agreement for the purchase, delivery to the designated location, assembly/installati
The Open-House procedure for pharmaceutical discount contracts involving the active ingredient Pazopanib (ATC L01EX03), identified by the code "484904-2024", will be terminated effective January 31, 2026. Existing contracts will be canceled at that time, and no new contracts can be concluded under t
This contract opportunity involves the establishment of non-exclusive discount contracts for the medication Glatiramer Acetate, specifically for pre-filled syringes. The contracts will be in effect from February 1, 2026, to January 31, 2028, with the option for suppliers to enter into contracts at a
This contract opportunity involves the establishment of non-exclusive discount contracts for the pharmaceutical products Naproxen and Esomeprazole, in accordance with German social law. The contracts will be valid from February 1, 2026, to January 31, 2028, and suppliers can enter into contracts at
Opportunity to deliver tiered adult weight management services combining community support (Tier 2) and specialist interventions (Tier 3) for comprehensive weight loss and health improvement programs.
Supply fixed accessibility and mobility equipment for disabled residents in Cambridge and Huntingdonshire via the HIA shared service programme.
Procurement for theratron medical equipment replacement and associated building infrastructure upgrades.
NHS Birmingham and Solihull ICB is seeking qualified providers for non-emergency patient transport services through a competitive procurement process.
